Galapagos (ADR) (GLPG)
Belgian biotech shifting from cell therapy toward partnered immunology and oncology assets.
$27.98
At close+0.47 (+1.71%)
Something off on this page? Send us feedback.
EPSReportedEstimate
Sep '24Oct '24Feb '25Apr '25Jul '25Nov '25Feb '26May '26
Reported$0.14−$0.77$0.39−$2.47−$1.89−$3.59$16.38$0.25
Estimate$0.03−$0.27−$0.24−$0.23−$0.67−$0.20$1.00−$1.27
Surprise+450.1%−185.2%+263.3%−973.9%−182.3%−1,696.4%+1,538.0%+119.7%
RevenueReportedEstimate
Sep '24Oct '24Feb '25Apr '25Jul '25Nov '25Feb '26May '26
Reported$83.7M$65.6M$78.2M$82.2M$76.9M$83.3M$1.24B$9.0M
Estimate$76.5M$78.2M—$78.2M$81.0M$80.1M$84.1M$11.3M
Surprise+9.4%−16.1%—+5.1%−5.1%+4.0%+1,370.9%−20.4%
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Aug 2026 | −$0.97 | — | — |
| May 2026 | −$1.27 | $0.25 | +119.7% |
| Feb 2026 | $1.00 | $16.38 | +1,538.0% |
| Nov 2025 | −$0.20 | −$3.59 | −1,696.4% |
| Jul 2025 | −$0.67 | −$1.89 | −182.3% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Apr 2025 | |||
| Feb 2025 | |||
| Oct 2024 | |||
| Sep 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Oct 2019 | |||
| Jul 2019 | |||
| Apr 2019 | |||
| Feb 2019 | |||
| Oct 2018 | |||
| Aug 2018 | |||
| Apr 2018 | |||
| Feb 2018 | |||
| Oct 2017 | |||
| Jul 2017 | |||
| Apr 2017 | |||
| Feb 2017 | |||
| Oct 2016 | |||
| Jul 2016 | |||
| Apr 2016 | |||
| Dec 2015 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| Mar 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | −$0.97 | — | — | $7.3M | — | — | — |
| May 6, 2026 | −$1.27 | $0.25 | +119.7% | $11.3M | $9.0M | −20.4% | −3.8% |
| Feb 23, 2026 | $1.00 | $16.38 | +1,538.0% | $84.1M | $1.24B | +1,370.9% | +1.5% |
| Nov 5, 2025 | −$0.20 | −$3.59 | −1,696.4% | $80.1M | $83.3M | +4.0% | +4.4% |
| Jul 23, 2025 | −$0.67 | −$1.89 | −182.3% | $81.0M | $76.9M | −5.1% | −7.3% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||||||
| Apr 23, 2025 | |||||||
| Feb 28, 2025 | |||||||
| Oct 30, 2024 | |||||||
| Sep 12, 2024 | |||||||
| May 2, 2024 | |||||||
| Feb 23, 2024 | |||||||
| Nov 3, 2023 | |||||||
| Aug 3, 2023 | |||||||
| May 4, 2023 | |||||||
| Feb 24, 2023 | |||||||
| Nov 3, 2022 | |||||||
| Aug 4, 2022 | |||||||
| May 5, 2022 | |||||||
| Feb 24, 2022 | |||||||
| Nov 5, 2021 | |||||||
| Aug 5, 2021 | |||||||
| May 6, 2021 | |||||||
| Feb 18, 2021 | |||||||
| Nov 5, 2020 | |||||||
| Aug 6, 2020 | |||||||
| May 7, 2020 | |||||||
| Feb 20, 2020 | |||||||
| Oct 24, 2019 | |||||||
| Jul 25, 2019 | |||||||
| Apr 26, 2019 | |||||||
| Feb 21, 2019 | |||||||
| Oct 26, 2018 | |||||||
| Aug 2, 2018 | |||||||
| Apr 25, 2018 | |||||||
| Feb 22, 2018 | |||||||
| Oct 24, 2017 | |||||||
| Jul 31, 2017 | |||||||
| Apr 27, 2017 | |||||||
| Feb 24, 2017 | |||||||
| Oct 26, 2016 | |||||||
| Jul 29, 2016 | |||||||
| Apr 28, 2016 | |||||||
| Dec 31, 2015 | |||||||
| Nov 13, 2015 | |||||||
| Aug 6, 2015 | |||||||
| Mar 6, 2015 | |||||||